DEVAJIT MOHAJAN; HARADHAN KUMAR MOHAJAN. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: New Oral Medications for the Treatment of Type 2 Diabetes. Innovation in Science and Technology, [S. l.], v. 3, n. 3, p. 31–35, 2024. Disponível em: https://www.paradigmpress.org/ist/article/view/1129. Acesso em: 30 apr. 2025.